Skip to Content

J&J COVID-19 Vaccine Should Be Used, but Carry Blood Clot Warning

TUESDAY, April 20, 2021 -- A warning about a possible link to rare blood clots should be added to the Johnson & Johnson/Janssen single-dose COVID-19 vaccine, the European Union (EU) drug regulator said Tuesday.

But the European Medicines Agency (EMA) also said the vaccine's benefits still far outweigh its risks and it did not recommend that member nations avoid using the vaccine, The New York Times reported. "The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of COVID-19 Vaccine Janssen in preventing COVID-19 outweigh the risks of side effects," the agency said in a statement about its nonbinding recommendation.

The rare clots associated with the Johnson & Johnson vaccine are "very similar" to those associated with the AstraZeneca vaccine, for which the EMA made a similar recommendation, The Times reported.

"Health care professionals and people who will receive the vaccine should be aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within three weeks of vaccination," the agency advised. It said an immune response may be one possible explanation for the rare blood clots.

The Johnson & Johnson vaccine has already been given to nearly 8 million people in the United States. However, U.S. regulators last week paused use of the vaccine due to concerns about six cases of the rare blood clots. That led Johnson & Johnson to delay the vaccine's rollout in the 27 EU member states, The Times reported. U.S. health officials said Monday they are investigating "a handful" of new, unconfirmed cases that have emerged since use of the vaccine was paused.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Read this next

Mental Health Poor for 11 Percent of U.K. Adults During COVID-19

WEDNESDAY, May 12, 2021 -- About 11 percent of U.K. adults experienced deteriorating or consistently poor mental health during the COVID-19 pandemic, according to a study...

NSAID Use Not Linked to Increased Mortality, Severity in COVID-19

WEDNESDAY, May 12, 2021 -- Nonsteroidal anti-inflammatory drug (NSAID) use is not associated with increased mortality or severity of COVID-19, according to a study published...

Third-Trimester COVID-19 Vaccination May Protect Infants

WEDNESDAY, May 12, 2021 -- Women receiving the COVID-19 vaccine in their third trimester of pregnancy generate a strong immune response and pass protective antibodies through...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.